New walking program aims to ease osteoarthritis pain with smart drug timing
NCT ID NCT05761015
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a walking program for people with painful hip or knee osteoarthritis. Participants take a nonsteroidal anti-inflammatory drug (NSAID) only before planned walks to reduce pain while avoiding long-term side effects. The program also includes proper footwear, education, and monitoring. The goal is to see if this approach helps people walk more and feel better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clemront-Ferrand
RECRUITINGClermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind-Body physio program aims to tackle chronic pain and depression together
- Can we decode the different types of pain in multiple sclerosis?
- Can yoga ease the pain of endometriosis after surgery?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Rewiring the brain to fight back pain?
- Could a common painkiller sabotage your knee treatment?